Tag Archives: michael Schöll

Nya medel till forskning om neurodegenerativa sjukdomar

Michael Schölls forskargrupp beviljades nyligen totalt 2 Mkr i ALF-medel till projektet ”Translationell studie för att identifiera de tidiga patogena processerna som leder till neurodegenerativa sjukdomar”. Schöll är forskare vid Göteborgs universitet, Wallenberg Centre for Molecular and Translational Medicine och MedTech West. Från The Association for Frontotemporal Degeneration (AFTD) har Michael Schöll tillsammans med forskarkolleger vid…
Read more

New PET tau tracer outperforms established MRI measures

Michael Schöll Michael Schöll, Associate Professor at the Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg and MedTech West, is co-author of the article “Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders“, published in JAMA in September, 2018. To diagnose Alzheimer’s disease reliably is still…
Read more

The 2nd Biomarkers in Neurodegenerative Diseases course- next time in London

In April 2018 the inaugural Biomarkers in neurodegenerative diseases course took place at the University of Gothenburg, and now the 2nd Biomarkers in Neurodegenerative Diseases course will be held in April 2019 in Queen Square, London, as an exciting UCL/University of Gothenburg collaboration. Aimed at PhD level and beyond, this detailed and comprehensive 4 day…
Read more

First edition of “Biomarkers in neurodegenerative disorders” PhD course

The first edition of a new PhD course on Biomarkers in neurodegenerative disorders took place on 9-13 April at the University of Gothenburg’s Sahlgrenska Academy, Wallenberg Centre. The course featured lectures and interactive group assignments on a range of topics covering biomarkers in blood and cerebrospinal fluid, as well as PET and MRI-imaging of neurodegeneration…
Read more